Serveur d'exploration sur la méthode scrum

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice

Identifieur interne : 001F05 ( Istex/Corpus ); précédent : 001F04; suivant : 001F06

The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice

Auteurs : Uki Yamashita ; Takeshi Takami ; Toshiyuki Hamaoka ; Masayasu Kitagawa

Source :

RBID : ISTEX:108985EA5DA4842DC3888047C07A86F092CAB9B9

Abstract

In order to study the role of hapten-reactive helper T cells in the induction of autoimmunity in mice, an attempt was made to establish an experimental model for the development of hapten-reactive helper T cells and the termination of immunological tolerance against heterologous proteins. Spleen cells taken from mice which were immunized with hapten-isologous protein conjugates (PAB-MGG) demonstrated helper activity for the anti-DNP antibody response of DNP-primed B cells responding to DNP and PAB-conjugated protein, but spleen cells from hapten-heterologous protein conjugate (PAB-HGG)-primed mice could not respond to PAB-determinant. Thus, hapten-reactive helper T cells can develop in mice by the immunization with hapten-isologous protein conjugate, but not with hapten-heterologous protein conjugate. However, spleen cells from mice which had been rendered tolerant by treatment with 2.5 or 0.2 mg of DHGG and then immunized with PAB-HGG could demonstrate helper activity responding to PAB-determinant. This helper activity was PAB-specific, because these spleen cells did not demonstrate helper activity if PAB-determinant was omitted in the primary and the secondary antigen. This helper activity was abrogated by the treatment of spleen cells with anti-θ serum and complement. Thus, hapten-reactive helper T cells were successfully induced by the challenge with hapten-heterologous protein conjugate in carrier-protein tolerant mice. When mice were treated with 2.5 or 0.2 mg of DHGG, no anti-HGG antibody response was induced by the challenge with HGG or PAB-HGG. However, the termination of HGG-tolerance was demonstrated only when the mice were preimmunized with PAB-MGG to raise PAB-rcactive helper T cells, treated with 0.2 mg of DHGG, and then challenged with PAB-HGG. This termination of immunological tolerance was not observed when the mice were preimmunized with PAB-BαA to raise PAB-specific B cells and anti-PAB antibody, or when the mice were treated with 2.5 mg of DHGG. Thus, if HGG-specific B cells remain intact in mice such as treated with low dose of DHGG, these B cells can be activated by some bypass mechanisms in the presence of PAB-reactive helper T cells through the PAB-determinant even in the absence of HGG-reactive helper T cells. These data clearly showed the role of hapten-reactive helper T cells in the termination of immunological tolerance and provide experimental supports to the hypothesis on the termination mechanism proposed by Weigle. The cellular mechanism for the development of hapten-reactive helper T cells in tolerant animals and the cellular mechanism of autoantibody production were discussed on the basis of T-B cell collaboration.

Url:
DOI: 10.1016/0008-8749(76)90093-9

Links to Exploration step

ISTEX:108985EA5DA4842DC3888047C07A86F092CAB9B9

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice</title>
<author>
<name sortKey="Yamashita, Uki" sort="Yamashita, Uki" uniqKey="Yamashita U" first="Uki" last="Yamashita">Uki Yamashita</name>
<affiliation>
<mods:affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Takami, Takeshi" sort="Takami, Takeshi" uniqKey="Takami T" first="Takeshi" last="Takami">Takeshi Takami</name>
<affiliation>
<mods:affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hamaoka, Toshiyuki" sort="Hamaoka, Toshiyuki" uniqKey="Hamaoka T" first="Toshiyuki" last="Hamaoka">Toshiyuki Hamaoka</name>
<affiliation>
<mods:affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kitagawa, Masayasu" sort="Kitagawa, Masayasu" uniqKey="Kitagawa M" first="Masayasu" last="Kitagawa">Masayasu Kitagawa</name>
<affiliation>
<mods:affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:108985EA5DA4842DC3888047C07A86F092CAB9B9</idno>
<date when="1976" year="1976">1976</date>
<idno type="doi">10.1016/0008-8749(76)90093-9</idno>
<idno type="url">https://api.istex.fr/document/108985EA5DA4842DC3888047C07A86F092CAB9B9/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001F05</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice</title>
<author>
<name sortKey="Yamashita, Uki" sort="Yamashita, Uki" uniqKey="Yamashita U" first="Uki" last="Yamashita">Uki Yamashita</name>
<affiliation>
<mods:affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Takami, Takeshi" sort="Takami, Takeshi" uniqKey="Takami T" first="Takeshi" last="Takami">Takeshi Takami</name>
<affiliation>
<mods:affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hamaoka, Toshiyuki" sort="Hamaoka, Toshiyuki" uniqKey="Hamaoka T" first="Toshiyuki" last="Hamaoka">Toshiyuki Hamaoka</name>
<affiliation>
<mods:affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kitagawa, Masayasu" sort="Kitagawa, Masayasu" uniqKey="Kitagawa M" first="Masayasu" last="Kitagawa">Masayasu Kitagawa</name>
<affiliation>
<mods:affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Cellular Immunology</title>
<title level="j" type="abbrev">YCIMM</title>
<idno type="ISSN">0008-8749</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1976">1976</date>
<biblScope unit="volume">25</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="15">15</biblScope>
<biblScope unit="page" to="31">31</biblScope>
</imprint>
<idno type="ISSN">0008-8749</idno>
</series>
<idno type="istex">108985EA5DA4842DC3888047C07A86F092CAB9B9</idno>
<idno type="DOI">10.1016/0008-8749(76)90093-9</idno>
<idno type="PII">0008-8749(76)90093-9</idno>
<idno type="ArticleID">76900939</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0008-8749</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In order to study the role of hapten-reactive helper T cells in the induction of autoimmunity in mice, an attempt was made to establish an experimental model for the development of hapten-reactive helper T cells and the termination of immunological tolerance against heterologous proteins. Spleen cells taken from mice which were immunized with hapten-isologous protein conjugates (PAB-MGG) demonstrated helper activity for the anti-DNP antibody response of DNP-primed B cells responding to DNP and PAB-conjugated protein, but spleen cells from hapten-heterologous protein conjugate (PAB-HGG)-primed mice could not respond to PAB-determinant. Thus, hapten-reactive helper T cells can develop in mice by the immunization with hapten-isologous protein conjugate, but not with hapten-heterologous protein conjugate. However, spleen cells from mice which had been rendered tolerant by treatment with 2.5 or 0.2 mg of DHGG and then immunized with PAB-HGG could demonstrate helper activity responding to PAB-determinant. This helper activity was PAB-specific, because these spleen cells did not demonstrate helper activity if PAB-determinant was omitted in the primary and the secondary antigen. This helper activity was abrogated by the treatment of spleen cells with anti-θ serum and complement. Thus, hapten-reactive helper T cells were successfully induced by the challenge with hapten-heterologous protein conjugate in carrier-protein tolerant mice. When mice were treated with 2.5 or 0.2 mg of DHGG, no anti-HGG antibody response was induced by the challenge with HGG or PAB-HGG. However, the termination of HGG-tolerance was demonstrated only when the mice were preimmunized with PAB-MGG to raise PAB-rcactive helper T cells, treated with 0.2 mg of DHGG, and then challenged with PAB-HGG. This termination of immunological tolerance was not observed when the mice were preimmunized with PAB-BαA to raise PAB-specific B cells and anti-PAB antibody, or when the mice were treated with 2.5 mg of DHGG. Thus, if HGG-specific B cells remain intact in mice such as treated with low dose of DHGG, these B cells can be activated by some bypass mechanisms in the presence of PAB-reactive helper T cells through the PAB-determinant even in the absence of HGG-reactive helper T cells. These data clearly showed the role of hapten-reactive helper T cells in the termination of immunological tolerance and provide experimental supports to the hypothesis on the termination mechanism proposed by Weigle. The cellular mechanism for the development of hapten-reactive helper T cells in tolerant animals and the cellular mechanism of autoantibody production were discussed on the basis of T-B cell collaboration.</div>
</front>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<author>
<json:item>
<name>Uki Yamashita</name>
<affiliations>
<json:string>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</json:string>
</affiliations>
</json:item>
<json:item>
<name>Takeshi Takami</name>
<affiliations>
<json:string>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</json:string>
</affiliations>
</json:item>
<json:item>
<name>Toshiyuki Hamaoka</name>
<affiliations>
<json:string>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</json:string>
</affiliations>
</json:item>
<json:item>
<name>Masayasu Kitagawa</name>
<affiliations>
<json:string>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</json:string>
</affiliations>
</json:item>
</author>
<articleId>
<json:string>76900939</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>In order to study the role of hapten-reactive helper T cells in the induction of autoimmunity in mice, an attempt was made to establish an experimental model for the development of hapten-reactive helper T cells and the termination of immunological tolerance against heterologous proteins. Spleen cells taken from mice which were immunized with hapten-isologous protein conjugates (PAB-MGG) demonstrated helper activity for the anti-DNP antibody response of DNP-primed B cells responding to DNP and PAB-conjugated protein, but spleen cells from hapten-heterologous protein conjugate (PAB-HGG)-primed mice could not respond to PAB-determinant. Thus, hapten-reactive helper T cells can develop in mice by the immunization with hapten-isologous protein conjugate, but not with hapten-heterologous protein conjugate. However, spleen cells from mice which had been rendered tolerant by treatment with 2.5 or 0.2 mg of DHGG and then immunized with PAB-HGG could demonstrate helper activity responding to PAB-determinant. This helper activity was PAB-specific, because these spleen cells did not demonstrate helper activity if PAB-determinant was omitted in the primary and the secondary antigen. This helper activity was abrogated by the treatment of spleen cells with anti-θ serum and complement. Thus, hapten-reactive helper T cells were successfully induced by the challenge with hapten-heterologous protein conjugate in carrier-protein tolerant mice. When mice were treated with 2.5 or 0.2 mg of DHGG, no anti-HGG antibody response was induced by the challenge with HGG or PAB-HGG. However, the termination of HGG-tolerance was demonstrated only when the mice were preimmunized with PAB-MGG to raise PAB-rcactive helper T cells, treated with 0.2 mg of DHGG, and then challenged with PAB-HGG. This termination of immunological tolerance was not observed when the mice were preimmunized with PAB-BαA to raise PAB-specific B cells and anti-PAB antibody, or when the mice were treated with 2.5 mg of DHGG. Thus, if HGG-specific B cells remain intact in mice such as treated with low dose of DHGG, these B cells can be activated by some bypass mechanisms in the presence of PAB-reactive helper T cells through the PAB-determinant even in the absence of HGG-reactive helper T cells. These data clearly showed the role of hapten-reactive helper T cells in the termination of immunological tolerance and provide experimental supports to the hypothesis on the termination mechanism proposed by Weigle. The cellular mechanism for the development of hapten-reactive helper T cells in tolerant animals and the cellular mechanism of autoantibody production were discussed on the basis of T-B cell collaboration.</abstract>
<qualityIndicators>
<score>8</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>468 x 720 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>0</keywordCount>
<abstractCharCount>2696</abstractCharCount>
<pdfWordCount>6365</pdfWordCount>
<pdfCharCount>41797</pdfCharCount>
<pdfPageCount>17</pdfPageCount>
<abstractWordCount>400</abstractWordCount>
</qualityIndicators>
<title>The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice</title>
<pii>
<json:string>0008-8749(76)90093-9</json:string>
</pii>
<genre>
<json:string>research-article</json:string>
</genre>
<host>
<volume>25</volume>
<pii>
<json:string>S0008-8749(00)X0232-8</json:string>
</pii>
<pages>
<last>31</last>
<first>15</first>
</pages>
<issn>
<json:string>0008-8749</json:string>
</issn>
<issue>1</issue>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Cellular Immunology</title>
<publicationDate>1976</publicationDate>
</host>
<publicationDate>1976</publicationDate>
<copyrightDate>1976</copyrightDate>
<doi>
<json:string>10.1016/0008-8749(76)90093-9</json:string>
</doi>
<id>108985EA5DA4842DC3888047C07A86F092CAB9B9</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/108985EA5DA4842DC3888047C07A86F092CAB9B9/fulltext/pdf</uri>
</json:item>
<json:item>
<original>true</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/108985EA5DA4842DC3888047C07A86F092CAB9B9/fulltext/txt</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/108985EA5DA4842DC3888047C07A86F092CAB9B9/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/108985EA5DA4842DC3888047C07A86F092CAB9B9/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice</title>
<title level="a" type="sub" xml:lang="en">I. Establishment of the experimental conditions for the termination of immunological tolerance to human gamma globulin</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability>
<p>ELSEVIER</p>
</availability>
<date>1976</date>
</publicationStmt>
<notesStmt>
<note>This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Government.</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice</title>
<title level="a" type="sub" xml:lang="en">I. Establishment of the experimental conditions for the termination of immunological tolerance to human gamma globulin</title>
<author>
<persName>
<forename type="first">Uki</forename>
<surname>Yamashita</surname>
</persName>
<note type="biography">Present address: Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014.</note>
<affiliation>Present address: Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014.</affiliation>
<affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</affiliation>
</author>
<author>
<persName>
<forename type="first">Takeshi</forename>
<surname>Takami</surname>
</persName>
<affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</affiliation>
</author>
<author>
<persName>
<forename type="first">Toshiyuki</forename>
<surname>Hamaoka</surname>
</persName>
<note type="biography">To whom reprint requests should be sent.</note>
<affiliation>To whom reprint requests should be sent.</affiliation>
<affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</affiliation>
</author>
<author>
<persName>
<forename type="first">Masayasu</forename>
<surname>Kitagawa</surname>
</persName>
<affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Cellular Immunology</title>
<title level="j" type="abbrev">YCIMM</title>
<idno type="pISSN">0008-8749</idno>
<idno type="PII">S0008-8749(00)X0232-8</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1976"></date>
<biblScope unit="volume">25</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="15">15</biblScope>
<biblScope unit="page" to="31">31</biblScope>
</imprint>
</monogr>
<idno type="istex">108985EA5DA4842DC3888047C07A86F092CAB9B9</idno>
<idno type="DOI">10.1016/0008-8749(76)90093-9</idno>
<idno type="PII">0008-8749(76)90093-9</idno>
<idno type="ArticleID">76900939</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1976</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>In order to study the role of hapten-reactive helper T cells in the induction of autoimmunity in mice, an attempt was made to establish an experimental model for the development of hapten-reactive helper T cells and the termination of immunological tolerance against heterologous proteins. Spleen cells taken from mice which were immunized with hapten-isologous protein conjugates (PAB-MGG) demonstrated helper activity for the anti-DNP antibody response of DNP-primed B cells responding to DNP and PAB-conjugated protein, but spleen cells from hapten-heterologous protein conjugate (PAB-HGG)-primed mice could not respond to PAB-determinant. Thus, hapten-reactive helper T cells can develop in mice by the immunization with hapten-isologous protein conjugate, but not with hapten-heterologous protein conjugate. However, spleen cells from mice which had been rendered tolerant by treatment with 2.5 or 0.2 mg of DHGG and then immunized with PAB-HGG could demonstrate helper activity responding to PAB-determinant. This helper activity was PAB-specific, because these spleen cells did not demonstrate helper activity if PAB-determinant was omitted in the primary and the secondary antigen. This helper activity was abrogated by the treatment of spleen cells with anti-θ serum and complement. Thus, hapten-reactive helper T cells were successfully induced by the challenge with hapten-heterologous protein conjugate in carrier-protein tolerant mice. When mice were treated with 2.5 or 0.2 mg of DHGG, no anti-HGG antibody response was induced by the challenge with HGG or PAB-HGG. However, the termination of HGG-tolerance was demonstrated only when the mice were preimmunized with PAB-MGG to raise PAB-rcactive helper T cells, treated with 0.2 mg of DHGG, and then challenged with PAB-HGG. This termination of immunological tolerance was not observed when the mice were preimmunized with PAB-BαA to raise PAB-specific B cells and anti-PAB antibody, or when the mice were treated with 2.5 mg of DHGG. Thus, if HGG-specific B cells remain intact in mice such as treated with low dose of DHGG, these B cells can be activated by some bypass mechanisms in the presence of PAB-reactive helper T cells through the PAB-determinant even in the absence of HGG-reactive helper T cells. These data clearly showed the role of hapten-reactive helper T cells in the termination of immunological tolerance and provide experimental supports to the hypothesis on the termination mechanism proposed by Weigle. The cellular mechanism for the development of hapten-reactive helper T cells in tolerant animals and the cellular mechanism of autoantibody production were discussed on the basis of T-B cell collaboration.</p>
</abstract>
</profileDesc>
<revisionDesc>
<change when="1976-02-10">Received</change>
<change when="1976">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier, elements deleted: tail">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document>
<converted-article version="4.5.2" docsubtype="fla" xml:lang="en">
<item-info>
<jid>YCIMM</jid>
<aid>76900939</aid>
<ce:pii>0008-8749(76)90093-9</ce:pii>
<ce:doi>10.1016/0008-8749(76)90093-9</ce:doi>
<ce:copyright type="unknown" year="1976"></ce:copyright>
</item-info>
<head>
<ce:article-footnote>
<ce:label></ce:label>
<ce:note-para>This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Government.</ce:note-para>
</ce:article-footnote>
<ce:title>The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice</ce:title>
<ce:subtitle>I. Establishment of the experimental conditions for the termination of immunological tolerance to human gamma globulin</ce:subtitle>
<ce:author-group>
<ce:author>
<ce:given-name>Uki</ce:given-name>
<ce:surname>Yamashita</ce:surname>
<ce:cross-ref refid="FN1">
<ce:sup loc="post">2</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Takeshi</ce:given-name>
<ce:surname>Takami</ce:surname>
</ce:author>
<ce:author>
<ce:given-name>Toshiyuki</ce:given-name>
<ce:surname>Hamaoka</ce:surname>
<ce:cross-ref refid="COR1">
<ce:sup loc="post">3</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Masayasu</ce:given-name>
<ce:surname>Kitagawa</ce:surname>
</ce:author>
<ce:affiliation>
<ce:textfn>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</ce:textfn>
</ce:affiliation>
<ce:correspondence id="COR1">
<ce:label>3</ce:label>
<ce:text>To whom reprint requests should be sent.</ce:text>
</ce:correspondence>
<ce:footnote id="FN1">
<ce:label>2</ce:label>
<ce:note-para>Present address: Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014.</ce:note-para>
</ce:footnote>
</ce:author-group>
<ce:date-received day="10" month="2" year="1976"></ce:date-received>
<ce:abstract class="author">
<ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec>
<ce:simple-para view="all" id="simple-para.0010">In order to study the role of hapten-reactive helper T cells in the induction of autoimmunity in mice, an attempt was made to establish an experimental model for the development of hapten-reactive helper T cells and the termination of immunological tolerance against heterologous proteins. Spleen cells taken from mice which were immunized with hapten-isologous protein conjugates (PAB-MGG) demonstrated helper activity for the anti-DNP antibody response of DNP-primed B cells responding to DNP and PAB-conjugated protein, but spleen cells from hapten-heterologous protein conjugate (PAB-HGG)-primed mice could not respond to PAB-determinant. Thus, hapten-reactive helper T cells can develop in mice by the immunization with hapten-isologous protein conjugate, but not with hapten-heterologous protein conjugate. However, spleen cells from mice which had been rendered tolerant by treatment with 2.5 or 0.2 mg of DHGG and then immunized with PAB-HGG could demonstrate helper activity responding to PAB-determinant. This helper activity was PAB-specific, because these spleen cells did not demonstrate helper activity if PAB-determinant was omitted in the primary and the secondary antigen. This helper activity was abrogated by the treatment of spleen cells with anti-θ serum and complement. Thus, hapten-reactive helper T cells were successfully induced by the challenge with hapten-heterologous protein conjugate in carrier-protein tolerant mice. When mice were treated with 2.5 or 0.2 mg of DHGG, no anti-HGG antibody response was induced by the challenge with HGG or PAB-HGG. However, the termination of HGG-tolerance was demonstrated only when the mice were preimmunized with PAB-MGG to raise PAB-rcactive helper T cells, treated with 0.2 mg of DHGG, and then challenged with PAB-HGG. This termination of immunological tolerance was not observed when the mice were preimmunized with PAB-BαA to raise PAB-specific B cells and anti-PAB antibody, or when the mice were treated with 2.5 mg of DHGG. Thus, if HGG-specific B cells remain intact in mice such as treated with low dose of DHGG, these B cells can be activated by some bypass mechanisms in the presence of PAB-reactive helper T cells through the PAB-determinant even in the absence of HGG-reactive helper T cells. These data clearly showed the role of hapten-reactive helper T cells in the termination of immunological tolerance and provide experimental supports to the hypothesis on the termination mechanism proposed by Weigle. The cellular mechanism for the development of hapten-reactive helper T cells in tolerant animals and the cellular mechanism of autoantibody production were discussed on the basis of T-B cell collaboration.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice</title>
<subTitle>I. Establishment of the experimental conditions for the termination of immunological tolerance to human gamma globulin</subTitle>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA">
<title>The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice</title>
<subTitle>I. Establishment of the experimental conditions for the termination of immunological tolerance to human gamma globulin</subTitle>
</titleInfo>
<name type="personal">
<namePart type="given">Uki</namePart>
<namePart type="family">Yamashita</namePart>
<affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</affiliation>
<description>Present address: Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Takeshi</namePart>
<namePart type="family">Takami</namePart>
<affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Toshiyuki</namePart>
<namePart type="family">Hamaoka</namePart>
<affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</affiliation>
<description>To whom reprint requests should be sent.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Masayasu</namePart>
<namePart type="family">Kitagawa</namePart>
<affiliation>Institute for Cancer Research, Osaka University Medical School, Dojimahamadori, Fukushimaku, Osaka, Japan</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article"></genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1976</dateIssued>
<dateCaptured encoding="w3cdtf">1976-02-10</dateCaptured>
<copyrightDate encoding="w3cdtf">1976</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">In order to study the role of hapten-reactive helper T cells in the induction of autoimmunity in mice, an attempt was made to establish an experimental model for the development of hapten-reactive helper T cells and the termination of immunological tolerance against heterologous proteins. Spleen cells taken from mice which were immunized with hapten-isologous protein conjugates (PAB-MGG) demonstrated helper activity for the anti-DNP antibody response of DNP-primed B cells responding to DNP and PAB-conjugated protein, but spleen cells from hapten-heterologous protein conjugate (PAB-HGG)-primed mice could not respond to PAB-determinant. Thus, hapten-reactive helper T cells can develop in mice by the immunization with hapten-isologous protein conjugate, but not with hapten-heterologous protein conjugate. However, spleen cells from mice which had been rendered tolerant by treatment with 2.5 or 0.2 mg of DHGG and then immunized with PAB-HGG could demonstrate helper activity responding to PAB-determinant. This helper activity was PAB-specific, because these spleen cells did not demonstrate helper activity if PAB-determinant was omitted in the primary and the secondary antigen. This helper activity was abrogated by the treatment of spleen cells with anti-θ serum and complement. Thus, hapten-reactive helper T cells were successfully induced by the challenge with hapten-heterologous protein conjugate in carrier-protein tolerant mice. When mice were treated with 2.5 or 0.2 mg of DHGG, no anti-HGG antibody response was induced by the challenge with HGG or PAB-HGG. However, the termination of HGG-tolerance was demonstrated only when the mice were preimmunized with PAB-MGG to raise PAB-rcactive helper T cells, treated with 0.2 mg of DHGG, and then challenged with PAB-HGG. This termination of immunological tolerance was not observed when the mice were preimmunized with PAB-BαA to raise PAB-specific B cells and anti-PAB antibody, or when the mice were treated with 2.5 mg of DHGG. Thus, if HGG-specific B cells remain intact in mice such as treated with low dose of DHGG, these B cells can be activated by some bypass mechanisms in the presence of PAB-reactive helper T cells through the PAB-determinant even in the absence of HGG-reactive helper T cells. These data clearly showed the role of hapten-reactive helper T cells in the termination of immunological tolerance and provide experimental supports to the hypothesis on the termination mechanism proposed by Weigle. The cellular mechanism for the development of hapten-reactive helper T cells in tolerant animals and the cellular mechanism of autoantibody production were discussed on the basis of T-B cell collaboration.</abstract>
<note>This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Government.</note>
<relatedItem type="host">
<titleInfo>
<title>Cellular Immunology</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>YCIMM</title>
</titleInfo>
<genre type="Journal">journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">197607</dateIssued>
</originInfo>
<identifier type="ISSN">0008-8749</identifier>
<identifier type="PII">S0008-8749(00)X0232-8</identifier>
<part>
<date>197607</date>
<detail type="volume">
<number>25</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>1</number>
<caption>no.</caption>
</detail>
<extent unit="issue pages">
<start>1</start>
<end>136</end>
</extent>
<extent unit="pages">
<start>15</start>
<end>31</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">108985EA5DA4842DC3888047C07A86F092CAB9B9</identifier>
<identifier type="DOI">10.1016/0008-8749(76)90093-9</identifier>
<identifier type="PII">0008-8749(76)90093-9</identifier>
<identifier type="ArticleID">76900939</identifier>
<recordInfo>
<recordContentSource>ELSEVIER</recordContentSource>
</recordInfo>
</mods>
</metadata>
<enrichments>
<istex:refBibTEI uri="https://api.istex.fr/document/108985EA5DA4842DC3888047C07A86F092CAB9B9/enrichments/refBib">
<teiHeader></teiHeader>
<text>
<front></front>
<body></body>
<back>
<listBibl>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">W</forename>
<forename type="middle">O</forename>
<surname>Weigle</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">J. Exp. Med</title>
<imprint>
<biblScope unit="volume">114</biblScope>
<biblScope unit="page">111</biblScope>
<date type="published" when="1961"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">W</forename>
<forename type="middle">O</forename>
<surname>Weigle</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">J. Exp. Med</title>
<imprint>
<biblScope unit="volume">116</biblScope>
<biblScope unit="page">913</biblScope>
<date type="published" when="1962"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">W</forename>
<forename type="middle">O</forename>
<surname>Weigle</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">/</forename>
</persName>
</author>
</analytic>
<monogr>
<title level="j">Exp. Med</title>
<imprint>
<biblScope unit="volume">121</biblScope>
<biblScope unit="issue">289</biblScope>
<date type="published" when="1965"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">W</forename>
<forename type="middle">O</forename>
<surname>Weigle</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">Cl&. Exp. Immatnol</title>
<imprint>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">437</biblScope>
<date type="published" when="1971"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<surname>Katz</surname>
</persName>
</author>
<author>
<persName>
<surname>Ii</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">R</forename>
<surname>Bcnaccrraf</surname>
</persName>
</author>
<author>
<persName>
<surname>Ix</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">~(~vaiices in Immu~~oloc~ J. l)</title>
<imprint>
<biblScope unit="volume">11</biblScope>
<biblScope unit="issue">11</biblScope>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic></analytic>
<monogr>
<title level="j">Kunkcl, t</title>
<imprint>
<publisher>Academic Press. Scn \'~~l-I~</publisher>
<publisher>Academic Press. Scn \'~~l-I~</publisher>
<biblScope unit="volume">15</biblScope>
<biblScope unit="issue">1</biblScope>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">Z</forename>
<surname>Fj</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">J</forename>
<surname>Chiller</surname>
</persName>
</author>
<author>
<persName>
<surname>\i</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">G</forename>
<forename type="middle">S</forename>
<surname>Haljicht</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">\I:. o., .S~</title>
<imprint>
<biblScope unit="volume">171</biblScope>
<biblScope unit="page" from="81" to="3"></biblScope>
<date type="published" when="1971"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<title level="m" type="main">Advances in Immunology " (H. J. I)iuon ant1 II. (;. Kunkcl. lrcl\ 1, \'ol</title>
<author>
<persName>
<forename type="first">R-. 0.</forename>
<surname>\veigle</surname>
</persName>
</author>
<author>
<persName>
<surname>Ii~</surname>
</persName>
</author>
<imprint>
<date type="published" when="1973"></date>
<publisher>Academic Press</publisher>
<biblScope unit="page">61</biblScope>
<pubPlace>Kew York</pubPlace>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">J</forename>
<surname>Chiller</surname>
</persName>
</author>
<author>
<persName>
<surname>Xl</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">W</forename>
<forename type="middle">O</forename>
<surname>Weigle</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">J</forename>
<surname>Erp</surname>
</persName>
</author>
<imprint>
<date type="published" when="1973"></date>
<biblScope unit="page">710</biblScope>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">G</forename>
<forename type="middle">J</forename>
<surname>Fournic</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">P</forename>
<forename type="middle">H</forename>
<surname>Lambert</surname>
</persName>
</author>
<imprint>
<date type="published" when="1971"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">I</forename>
<surname>Kachtigal</surname>
</persName>
</author>
</monogr>
<note>S3. .%1. 100.3</note>
</biblStruct>
<biblStruct>
<monogr>
<title level="m" type="main">H. 11.. J. I~r~?rllol</title>
<author>
<persName>
<surname>Dietrich</surname>
</persName>
</author>
<imprint>
<date type="published" when="1966"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">Paul</forename>
<forename type="middle">M '. I ;.</forename>
<surname>Thorbeckr</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">G</forename>
<forename type="middle">J G W</forename>
<surname>Siskind</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">antI Rrnaccrraf</title>
<imprint>
<biblScope unit="volume">85</biblScope>
<biblScope unit="page" from="1" to="17"></biblScope>
<date type="published" when="1960"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">J</forename>
<surname>Clagett</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">\</forename>
<surname>Weigle</surname>
</persName>
</author>
<author>
<persName>
<forename type="middle">O</forename>
<surname>\i '</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">J. Exp. dlrd</title>
<imprint>
<biblScope unit="volume">139</biblScope>
<biblScope unit="page">043</biblScope>
<date type="published" when="1974"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">J</forename>
<forename type="middle">H L</forename>
<surname>Playfair</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">S</forename>
<surname>Marshall-Clarke</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="m">Natz{rr (~V:iw Ijio2.) 243</title>
<imprint>
<date type="published" when="1973"></date>
<biblScope unit="page">213</biblScope>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">Cox</forename>
<forename type="middle">K O</forename>
<surname>Keast</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">I</forename>
</persName>
</author>
<imprint>
<date type="published" when="1973"></date>
<biblScope unit="page">531</biblScope>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="first">U</forename>
<surname>Yamashita</surname>
</persName>
</author>
<author>
<persName>
<surname>Kitagawa</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">Cell. I~zwr~ol</title>
<imprint>
<biblScope unit="volume">14</biblScope>
<biblScope unit="issue">182</biblScope>
<date type="published" when="1974"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<forename type="middle">U</forename>
<surname>Yamashita</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">T</forename>
<surname>Takami</surname>
</persName>
</author>
<author>
<persName>
<surname>Kitagawa</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">Crll. ~WM~IZI~I</title>
<imprint>
<biblScope unit="volume">18</biblScope>
<biblScope unit="page">396</biblScope>
<date type="published" when="1975"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">H</forename>
<forename type="middle">S</forename>
<surname>Eisen</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">.</forename>
<surname>Krq</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">\v</forename>
<forename type="middle">T</forename>
<surname>Newton</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">E</forename>
<surname>Helmreich</surname>
</persName>
</author>
<imprint>
<date type="published" when="1950"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">I</forename>
<forename type="middle">N</forename>
<surname>Eisen</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">M</forename>
<forename type="middle">E</forename>
<surname>Carsten</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">S</forename>
<forename type="middle">J</forename>
<surname>Belman</surname>
</persName>
</author>
<author>
<persName>
<surname>1~111~</surname>
</persName>
</author>
<imprint>
<date type="published" when="1101"></date>
<biblScope unit="page">296</biblScope>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<analytic>
<author>
<persName>
<surname>Tabachnick</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">H</forename>
<surname>Sobotka</surname>
</persName>
</author>
</analytic>
<monogr>
<title level="j">J. njol. Ch(*r~f. Tahachnick. RI.. and Sohotka, H., J. Riol. Chr~</title>
<editor>I. J., and Szenberg. A.</editor>
<imprint>
<publisher>Cunningham</publisher>
<publisher>Cunningham</publisher>
<biblScope unit="volume">234</biblScope>
<biblScope unit="issue">559</biblScope>
<date type="published" when="1726"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<surname>Kishimoto</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">I</forename>
<surname>Tsuyuguchi</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">Y</forename>
<surname>Yamamura</surname>
</persName>
</author>
<author>
<persName>
<surname>Ijlt</surname>
</persName>
</author>
<imprint>
<date type="published" when="1968"></date>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">I<</forename>
<surname>Goluh</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">R</forename>
<forename type="middle">I</forename>
<surname>~fiskll</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">W</forename>
<forename type="middle">O</forename>
<surname>1veigle</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">I<</forename>
<surname>Imton</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">-.</forename>
<surname>I\</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">J</forename>
</persName>
</author>
<imprint>
<biblScope unit="page" from="133" to="106"></biblScope>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">T</forename>
<surname>Ilamaoka</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">U</forename>
<surname>Yamashita</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">T</forename>
<surname>Takami</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">Ai</forename>
<surname>Kitaga\\a</surname>
</persName>
</author>
<imprint>
<date type="published" when="1975"></date>
<biblScope unit="page">13</biblScope>
</imprint>
</monogr>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">U</forename>
<surname>Yamashita</surname>
</persName>
</author>
</monogr>
<note>Unpuhlishcd. observation</note>
</biblStruct>
<biblStruct>
<monogr>
<author>
<persName>
<forename type="first">H</forename>
<forename type="middle">J</forename>
<surname>Schwartz</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">S</forename>
<surname>Leskowitz</surname>
</persName>
</author>
<author>
<persName>
<forename type="first">I</forename>
<surname>Pyoc</surname>
</persName>
</author>
<editor>28. l~ullock, \V. IV,, Katz, D. H., and Benacerraf, IS.</editor>
<imprint>
<date type="published" when="1968"></date>
</imprint>
</monogr>
</biblStruct>
</listBibl>
</back>
</text>
</istex:refBibTEI>
</enrichments>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Informatique/explor/ScrumV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F05 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001F05 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Informatique
   |area=    ScrumV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:108985EA5DA4842DC3888047C07A86F092CAB9B9
   |texte=   The role of hapten-reactive T lymphocytes in the induction of autoimmunity in mice
}}

Wicri

This area was generated with Dilib version V0.6.39.
Data generation: Tue Mar 5 18:28:08 2024. Site generation: Tue Mar 5 18:45:01 2024